title: Serotonin syndrome, rhabdomyolysis and convulsion associated with drug interaction between venlafaxine and amoxicillin/clavulanic acid.
authors.affiliation: Servicio de Farmacia, Xerencia Xestión Integrada Santiago de Compostela (SERGAS) Grupo Farmacología Clínica. Instituto de Investigación Sanitaria, Santiago de Compostela (IDIS-ISCIII).
authors.forename: Anxo
authors.initials: A
authors.lastname: Fernández-Ferreiro
authors.affiliation: Unidade Pluripatoloxía e Idade Avanzada, Medicina Interna, Xerencia Xestión Integrada Santiago de Compostela (SERGAS).
authors.forename: Antonio
authors.initials: A
authors.lastname: Pose-Reino
authors.affiliation: Servicio de Farmacia, Xerencia Xestión Integrada Santiago de Compostela (SERGAS).
authors.forename: Francisco
authors.initials: F
authors.lastname: Martinez-Bahamonde
authors.affiliation: UFR Sciences Pharmaceutiques et Ingiénerie de la Santé, Université d&#8217;Angers.
authors.forename: Marion
authors.initials: M
authors.lastname: Paris
authors.affiliation: UFR Sciences Pharmaceutiques et Ingiénerie de la Santé, Université d&#8217;Angers.
authors.forename: Emilie
authors.initials: E
authors.lastname: Guemas
authors.affiliation: Servicio de Farmacia, Xerencia Xestión Integrada Santiago de Compostela (SERGAS) Grupo Farmacología Clínica. Instituto de Investigación Sanitaria, Santiago de Compostela (IDIS-ISCIII).
authors.forename: Miguel
authors.initials: M
authors.lastname: González-Barcia
authors.affiliation: Servicio de Farmacia, Xerencia Xestión Integrada Santiago de Compostela (SERGAS) Grupo Farmacología Clínica. Instituto de Investigación Sanitaria, Santiago de Compostela (IDIS-ISCIII).
authors.forename: M J
authors.initials: MJ
authors.lastname: Lamas
mesh_terms: D000368:Aged; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D012206:Rhabdomyolysis / Q000139:chemically induced*; D012640:Seizures / Q000139:chemically induced*; D020230:Serotonin Syndrome / Q000209:etiology*; D000068760:Serotonin and Noradrenaline Reuptake Inhibitors / Q000009:adverse effects*; D000069470:Venlafaxine Hydrochloride / Q000009:adverse effects*; D065093:beta-Lactamase Inhibitors / Q000009:adverse effects*
chemical_list: D000068760:Serotonin and Noradrenaline Reuptake Inhibitors; D065093:beta-Lactamase Inhibitors; D019980:Amoxicillin-Potassium Clavulanate Combination; D000069470:Venlafaxine Hydrochloride